Evaluating the Risks and Benefits of Phase II and III Clinical Cancer Trials: A Look at Institutional Review Board Members in the Netherlands
van Luijn, H.E.M.
IRB: Ethics and Human Research 2007 January-February; 29(1): 13-17
Showing items related by title, author, creator and subject.
The Evaluation of the Risks and Benefits of Phase II Cancer Clinical Trials by Institutional Review Boards (IRB) Members: A Case Study van Luijn, H.E.M.; Aaronson, N.K.; Keus, R.B.; Musschenga, A.W. (2006-03)There are indications that institutional review board (IRB) members do not find it easy to assess the risks and benefits in medical experiments, although this is their principal duty. This study examined how IRB members ...
Risks and Benefits of Phase 1 Clinical Trials Evaluating New Anticancer Agents: A Case for More Innovation Chen, Eric X.; Tannock, Ian F. (2004-11-03)
Protecting Research Participants Review of Institutional Review Boards: Management and Function, Edited by R.J. Amdur and E.A. Bankert; Institutional Review Board: Member Handbook, by R. Amdur; Study Guide for Institutional Review Board: Management and Function, by S. Kornetsky, A. Davis, and R.J. Amdur; Principles of Clinical Research, Edited by I. Di Giovanna and G. Hayes; Informed Consent in Medical Research, Edited by L. Doyal and J.S. Tobias; the Complete Guide to Informed Consent in Clinical Trials, Edited by T. Hartnett; Tuskegee's Truths: Rethinking the Tuskegee Syphilis Study, Edited by S.M. Reverby; European Neonatal Research: Consent, Ethics Committees and Law, Edited by S. Mason and C. Megone; the Ethics of Medical Research on Humans, by C. Foster; Ethical Issues in Biomedical Publication, Edited by A. Hudson Jones and F. McLellan; Fraud and Misconduct in Biomedical Research (3rd Edition), Edited by S. Lock, F. Wells, and M. Farthing; Biomedical Research Ethics: Updating International Guidel Nicholson, Richard (2002-11)